Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
73 studies found for:    Open Studies | "Warfarin"
Show Display Options
Rank Status Study
21 Recruiting Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: edoxaban;   Drug: Enoxaparin;   Drug: Warfarin
22 Recruiting Therapeutic Equivalence Between Branded and Generic Warfarin Tablets in Brazil
Condition: Atrial Fibrillation
Interventions: Drug: Marevan®;   Drug: generic warfarin #1;   Drug: generic warfarin #2
23 Not yet recruiting Randomized Controlled Feasibility Trial of the Fearon Algorithm to Improve Management of Unstable Warfarin
Condition: Hypoprothrombinemia
Interventions: Other: Warfarin adjustment using the Fearon algorithm;   Other: Warfarin adjustment using standard dosing
24 Not yet recruiting Cerebral Microbleeds During NOACs or Warfarin Therapy in NVAF Patients With Acute Ischemic Stroke (CMB-NOW)
Conditions: Ischemic Stroke;   Cerebral Microbleeds;   Atrial Fibrillation Symptomatic
Intervention:
25 Unknown  Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized Trial
Condition: Anticoagulation
Interventions: Drug: warfarin;   Drug: Warfarin
26 Recruiting Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients
Condition: Advanced Solid Tumor
Interventions: Drug: LDE225;   Drug: Wafarin;   Drug: Bupropion
27 Recruiting Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium
Condition: Atherosclerosis
Interventions: Drug: rivaroxaban;   Drug: Warfarin
28 Unknown  Determinants of Warfarin Metabolism
Condition: Healthy
Interventions: Drug: Warfarin;   Drug: Phenytoin
29 Unknown  Genetic Determinants of Warfarin Anticoagulation Effect
Conditions: Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation
Intervention: Drug: Warfarin
30 Recruiting Genotype-guided Warfarin Individualized Treatment
Conditions: Atrial Fibrillation;   Deep Venous Thrombosis
Interventions: Behavioral: Genotype-guided dosing algorithm for warfarin;   Behavioral: Standard initiation dose for warfarin
31 Not yet recruiting A Clinical Study of Lyophilized Plasma in Patients on Warfarin
Condition: Anticoagulant Therapy
Interventions: Biological: Lyophilized Plasma;   Biological: Licensed Plasma
32 Recruiting Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation
Conditions: Ischemic Stroke;   Transient Ischemic Attack
Interventions: Drug: Rivaroxaban;   Drug: Warfarin
33 Unknown  Pharmacogenetic Study of Warfarin Dose-Response: a Prospective Trial
Condition: Cardiovascular Diseases
Intervention:
34 Unknown  Relationship Between Folic Acid and Warfarin Metabolism and Effect
Condition: Folic Acid Deficiency
Intervention: Drug: Folic acid
35 Recruiting Short Term Warfarin Therapy for Radiofrequency Catheter Ablation of Atrial Fibrillation
Condition: Atrial Fibrillation
Intervention: Drug: warfarin
36 Not yet recruiting Effect of BI 1181181 on Midazolam, Warfarin, Omeprazole and Digoxin
Condition: Healthy
Interventions: Drug: Omeprazole;   Drug: Warfarin;   Drug: BI 1181181;   Drug: Midazolam;   Drug: Digoxin
37 Recruiting Blood Donation From Warfarin Users for the Development of POC INR Monitor
Conditions: Atrial Fibrillation;   Pulmonary Embolism;   Deep Vein Thrombosis
Intervention: Procedure: Venepuncture
38 Recruiting Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"
Conditions: Atrial Fibrillation;   Coronary Artery Disease
Interventions: Drug: Ticagrelor+Warfarin;   Drug: Clopidogrel+Aspirin+Warfarin
39 Recruiting Safety and Efficacy Study of LAmbre LAA Closure Device for Treating AF Patients Who Cannot Take Warfarin
Condition: Atrial Fibrillation
Intervention: Device: LAA closure system
40 Not yet recruiting Drug-Drug Interaction Potential of Orbactiv (Oritavancin) Co-Administered With Warfarin in Healthy Subjects
Condition: Healthy
Interventions: Drug: Single-Dose IV Oritavancin Diphosphate and Warfarin;   Drug: Single-Dose IV Oritavancin Diphosphate and Warfarin 24 hour post dose

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years